Mesoblast Limited (MEOBF)
PNK: MEOBF
· Real-Time Price · USD
1.44
0.00 (0.00%)
At close: Apr 30, 2025, 9:30 AM
0.00% (1D)
| Bid | 1.21 |
| Market Cap | 1.84B |
| Revenue (ttm) | 5.9M |
| Net Income (ttm) | -87.96M |
| EPS (ttm) | -0.09 |
| PE Ratio (ttm) | -16 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.67 |
| Volume | 1,000 |
| Avg. Volume (20D) | 39,462 |
| Open | 1.50 |
| Previous Close | 1.44 |
| Day's Range | 1.44 - 1.50 |
| 52-Week Range | 0.56 - 5.34 |
| Beta | 2.03 |
About MEOBF
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchyma...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 15, 2010
Employees 73
Stock Exchange PNK
Ticker Symbol MEOBF
Website https://www.mesoblast.com